These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 26026214

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children.
    Nobili V, Alisi A, Della Corte C, Risé P, Galli C, Agostoni C, Bedogni G.
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1066-70. PubMed ID: 23220074
    [Abstract] [Full Text] [Related]

  • 4. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L, Di Martino M, Anania C, Andreoli GM, Bezzi M, Catalano C, Chiesa C.
    World J Gastroenterol; 2015 Apr 21; 21(15):4688-95. PubMed ID: 25914480
    [Abstract] [Full Text] [Related]

  • 5. Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease.
    Granér M, Nyman K, Siren R, Pentikäinen MO, Lundbom J, Hakkarainen A, Lauerma K, Lundbom N, Nieminen MS, Taskinen MR.
    Circ Cardiovasc Imaging; 2015 Jan 21; 8(1):. PubMed ID: 25550397
    [Abstract] [Full Text] [Related]

  • 6. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
    Fishbein MH, Mogren C, Gleason T, Stevens WR.
    J Pediatr Gastroenterol Nutr; 2006 Jan 21; 42(1):83-8. PubMed ID: 16385259
    [Abstract] [Full Text] [Related]

  • 7. Docosahexaenoic acid prevents trans-10, cis-12-conjugated linoleic acid-induced nonalcoholic fatty liver disease in mice by altering expression of hepatic genes regulating fatty acid synthesis and oxidation.
    Fedor DM, Adkins Y, Mackey BE, Kelley DS.
    Metab Syndr Relat Disord; 2012 Jun 21; 10(3):175-80. PubMed ID: 22242926
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.
    Zöhrer E, Alisi A, Jahnel J, Mosca A, Della Corte C, Crudele A, Fauler G, Nobili V.
    Appl Physiol Nutr Metab; 2017 Sep 21; 42(9):948-954. PubMed ID: 28511023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial.
    Parker HM, Cohn JS, O'Connor HT, Garg ML, Caterson ID, George J, Johnson NA.
    Nutrients; 2019 Feb 23; 11(2):. PubMed ID: 30813440
    [Abstract] [Full Text] [Related]

  • 11. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F, Adibi P, Hekmatdoost A.
    Br J Nutr; 2015 Sep 14; 114(5):796-803. PubMed ID: 26234526
    [Abstract] [Full Text] [Related]

  • 12. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, Suman A, Weber M, Cusi K.
    Hepatology; 2015 Jan 14; 61(1):153-60. PubMed ID: 25145475
    [Abstract] [Full Text] [Related]

  • 13. Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
    Della Corte C, Carpino G, De Vito R, De Stefanis C, Alisi A, Cianfarani S, Overi D, Mosca A, Stronati L, Cucchiara S, Raponi M, Gaudio E, Byrne CD, Nobili V.
    PLoS One; 2016 Jan 14; 11(12):e0168216. PubMed ID: 27977757
    [Abstract] [Full Text] [Related]

  • 14. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
    Scorletti E, West AL, Bhatia L, Hoile SP, McCormick KG, Burdge GC, Lillycrop KA, Clough GF, Calder PC, Byrne CD.
    J Hepatol; 2015 Dec 14; 63(6):1476-83. PubMed ID: 26272871
    [Abstract] [Full Text] [Related]

  • 15. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
    Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L, Moyses HE, Calder PC, Byrne CD, WELCOME Study.
    Hepatology; 2014 Oct 14; 60(4):1211-21. PubMed ID: 25043514
    [Abstract] [Full Text] [Related]

  • 16. Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.
    Iacobellis G, Pellicelli AM, Grisorio B, Barbarini G, Leonetti F, Sharma AM, Barbaro G.
    Obesity (Silver Spring); 2008 Jan 14; 16(1):179-83. PubMed ID: 18223632
    [Abstract] [Full Text] [Related]

  • 17. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L, Scorletti E, Curzen N, Clough GF, Calder PC, Byrne CD.
    Atherosclerosis; 2016 Mar 14; 246():13-20. PubMed ID: 26748347
    [Abstract] [Full Text] [Related]

  • 18. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
    Oscarsson J, Önnerhag K, Risérus U, Sundén M, Johansson L, Jansson PA, Moris L, Nilsson PM, Eriksson JW, Lind L.
    J Clin Lipidol; 2018 Mar 14; 12(6):1390-1403.e4. PubMed ID: 30197273
    [Abstract] [Full Text] [Related]

  • 19. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L, Bonci E, Marandola L, Romaggioli S, Bascetta S, Chiesa C.
    World J Gastroenterol; 2014 Dec 07; 20(45):17107-14. PubMed ID: 25493023
    [Abstract] [Full Text] [Related]

  • 20. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM, Farghaly AG, El-Ghitany EM.
    Arab J Gastroenterol; 2014 Jun 07; 15(2):76-81. PubMed ID: 25097051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.